DIBROMODULCITOL IN THE TREATMENT OF METASTATIC HEMANGIOPERICYTOMACONROY JF; RODA PI; SRIPRAYOON PRASASVINICHAI et al.1982; AMERICAN JOURNAL OF CLINICAL ONCOLOGY; ISSN 512273; USA; DA. 1982; VOL. 5; NO 4; PP. 453-456; BIBL. 9 REF.Article

EFFECT OF MANDROLONE PHENPROPIONATE ON MYELOPOIESISKAHN SB; CONROY JF; BRODSKY I et al.1974; J. MED. EXPER. CLIN.; SWITZ.; DA. 1974; VOL. 5; NO 6; PP. 303-309; BIBL. 1 P.Article

MALIGNANT PARAGANGLIOMA OF RETROPERITONEUM: LIGHT, ELECTRON MICROSCOPIC AND ULTRASONOGRAPHIC STUDYDAMJANOV I; SCHOCKER JD; KATZ SM et al.1981; UROLOGY (RIDGEWOOD); ISSN 0090-4295; USA; DA. 1981; VOL. 17; NO 6; PP. 611-615; BIBL. 13 REF.Article

LOW DOSE BLEOMYCIN AND METHOTREXATE IN CERVICAL CANCERCONROY JF; LEWIS GC; BRADY LW et al.1976; CANCER; U.S.A.; DA. 1976; VOL. 37; NO 2; PP. 660-664; BIBL. 11 REF.Article

CHEMOTHERAPY OF ADVANCED MEASURABLE COLON AND RECTAL CARCINOMA WITH ORAL 5-FLUOROURACIL ALONE OR IN COMBINATION WITH CYCLOPHOSPHAMIDE OR 6-THIOGUANINE, WITH INTREVENOUS 5-FLUOROURACIL OR BETA-2'-DEOXYTHIOGUANOSINE OR WITH ORAL 3(4-METHYL-CYCLOHEXYL)-1(2-CHLORETHYL)-1-NITROSOUREA. A PHASE II-III STUDY OF THE EASTERN COOPERATIVE ONCOLOGY GROUP (EST 4273)DOUGLASS HO JR; LAVIN PT; WOLL J et al.1978; CANCER; USA; DA. 1978; VOL. 42; NO 6; PP. 2538-2545; BIBL. 15 REF.Article